TP53 and head and neck squamous cell carcinoma: p53 mutation status can be utilized to predict the outcomes of radiotherapy and chemotherapy in HNSCC patients as per the observations chronicled by The Cancer Genome Atlas-based analysis of HNSCC patients [53].